RailTel Corporation Dividend Record Date on March 13: Interim Dividend of ₹1

RailTel Corporation has finalised March 13, 2026, as the record date for the interim dividend of ₹1, which was declared on March 9, 2026.
RailTel Corporation Ltd said in an exchange filing, “The Board of Directors have declared 2nd Interim dividend at the rate of 10% of paid-up share capital (Re 1/- per share). Further, the Board of Directors has also approved Friday, 13th March 2026 as "Record Date" for the purpose of payment of the 2nd interim dividend of FY 2025-26. The date of payment of dividend shall be Tuesday, 24th March 2026”
Also Read: IRFC ₹1.05 Interim Dividend Record Date is Tomorrow, March 13, 2026
RailTel Corporation Q3FY26 Highlights
For the quarter ended December 31, 2025, RailTel Corporation of India Ltd reported strong revenue growth, with total revenue from operations reaching ₹913.45 crore, up approximately 19% year-on-year from ₹767.62 crore in the same period last year. Profit after tax (PAT) for the quarter stood at ₹62.40 crore, reflecting a slight year-on-year decline of around 4%, primarily due to higher project execution costs.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Mar 12, 2026, 1:07 PM IST

Sachin Gupta
- RPG Life Sciences Share Price Crashes Over 10% After Q2 FY27 Results
- ACME Solar Share in Focus as Subsidiary Collaborates with NTPC on 400 MW Renewable Energy Project
- Hikal Share Price Gains Over 8%; Achieves Swissmedic GMP Certification for Bengaluru Facility
- Sun Pharma Share Price Gains Nearly 2%; Secures FDA Approval for ILUMYA in Treating Psoriatic Arthritis
- Best Long-Term Stocks in November 2026 Based on 5 Year CAGR: BSE, Adani Power and More




